Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with Filament Health Dr. Clive Ward-Able has been appointed as Medical Director, Head of Research & Development and Early Commercialization for Psyence ISO22000 certified commercial psilocybin production facility and lab upgraded Received an import permit…


Previous articlePT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women, Coaching, and Ketamine For Fibromyalgia
Next articleDiamond Therapeutics Achieves Last Patient Last Visit in Clinical Trial of Low-Dose Psilocybin